ArticleMolecular therapy oncolytics2022

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells i

Yingfang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.